Emily Sammons

7PUBLICATIONS
31CO-AUTHORS
Vision scienceMajor global burdens of diseasePharmacogenomicsCardiology (incl. cardiovascular diseases)Nephrology and urology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 12, 2026
Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial.

|Apr 03, 2025
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Feb 26, 2025
Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes.

Emily Sammons, Louise Bowman, William Stevens

|Nov 12, 2024
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.

Parminder K Judge, Katherine R Tuttle, Natalie Staplin

|Sep 15, 2024
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Jul 01, 2024
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

Pageof 2

Frequent Collaborators

4 joint publications

Jonathan Emberson

4 joint publications

Kaitlin J Mayne

4 joint publications

Richard Haynes

4 joint publications

Christoph Wanner